Teamwork Financial Advisors LLC Purchases New Stake in Danaher Co. (NYSE:DHR)

Teamwork Financial Advisors LLC purchased a new stake in shares of Danaher Co. (NYSE:DHR) in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,077 shares of the conglomerate’s stock, valued at approximately $519,000.

Several other institutional investors have also recently bought and sold shares of DHR. Tsfg LLC increased its position in shares of Danaher by 733.3% during the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 88 shares in the last quarter. Cape Investment Advisory Inc. acquired a new position in Danaher during the 4th quarter valued at about $25,000. BKM Wealth Management LLC acquired a new position in Danaher during the 4th quarter valued at about $27,000. Redmont Wealth Advisors LLC bought a new stake in Danaher during the 1st quarter worth approximately $30,000. Finally, Wetzel Investment Advisors Inc. purchased a new stake in shares of Danaher in the fourth quarter worth approximately $29,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Danaher

In other news, CEO Rainer Blair sold 47,175 shares of the company’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50. Following the transaction, the chief executive officer now owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Danaher news, Director Alan G. Spoon sold 708 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total value of $172,454.64. Following the completion of the transaction, the director now owns 116,202 shares of the company’s stock, valued at approximately $28,304,483.16. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Rainer Blair sold 47,175 shares of the firm’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the sale, the chief executive officer now owns 115,995 shares in the company, valued at approximately $28,908,273.90. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 148,783 shares of company stock valued at $37,536,717. Corporate insiders own 10.90% of the company’s stock.

Danaher Stock Performance

Danaher stock traded down $0.41 during midday trading on Thursday, reaching $240.00. The stock had a trading volume of 1,935,837 shares, compared to its average volume of 3,506,555. The company has a quick ratio of 1.51, a current ratio of 1.85 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $177.77 billion, a PE ratio of 40.68, a P/E/G ratio of 3.68 and a beta of 0.83. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $269.11. The firm’s 50-day moving average price is $255.67 and its 200 day moving average price is $246.91.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. Danaher’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same period last year, the firm earned $2.36 EPS. As a group, research analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.27 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is currently 18.31%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DHR. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, June 25th. Bank of America lifted their price objective on shares of Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a report on Wednesday, April 24th. Citigroup increased their target price on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a report on Wednesday, April 24th. Barclays boosted their price target on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. Finally, TD Cowen upped their price objective on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday, April 24th. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $268.67.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.